These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 37524929)
1. Prevention of contrast induced-acute kidney injury using coenzyme Q10 in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Ahmadimoghaddam D; Talebi SS; Rahmani A; Zamanirafe M; Parvaneh E; Ranjbar A; Poorolajal J; Mehrpooya M Eur J Clin Pharmacol; 2023 Oct; 79(10):1341-1356. PubMed ID: 37524929 [TBL] [Abstract][Full Text] [Related]
2. Association of radial versus femoral access with contrast-induced acute kidney injury in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction. Kolte D; Spence N; Puthawala M; Hyder O; Tuohy CP; Davidson CB; Sheldon MW; Laskey WK; Abbott JD Cardiovasc Revasc Med; 2016 Dec; 17(8):546-551. PubMed ID: 27566903 [TBL] [Abstract][Full Text] [Related]
3. Impact of small and dense low-density lipoprotein (sd-LDL)on contrast-induced acute kidney injury in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Li Y; Ma K; Shen G; Zheng D; Xuan Y; Li W Int Urol Nephrol; 2021 Dec; 53(12):2611-2617. PubMed ID: 33675477 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the preventive efficacy of rosuvastatin versus atorvastatin in post-contrast acute kidney injury in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention. Dai Y; Huang J; Zeng L; Huang Z; Duan C; Shao S; Chen H; Xue L; Chen J; Tan N; He P; Liu Y; Yu D Biomed Pharmacother; 2020 Aug; 128():110336. PubMed ID: 32521452 [TBL] [Abstract][Full Text] [Related]
5. Contrast Volume to Glomerular Filtration Ratio and Acute Kidney Injury among ST-Segment Elevation Myocardial Infarction Patients Treated with Primary Percutaneous Coronary Intervention. Zahler D; Rozenfeld KL; Merdler I; Peri Y; Shacham Y Cardiorenal Med; 2020; 10(2):108-115. PubMed ID: 31801134 [TBL] [Abstract][Full Text] [Related]
6. Impact of contrast-induced acute kidney injury on outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Kume K; Yasuoka Y; Adachi H; Noda Y; Hattori S; Araki R; Kohama Y; Imanaka T; Matsutera R; Kosugi M; Sasaki T Cardiovasc Revasc Med; 2013; 14(5):253-7. PubMed ID: 23993293 [TBL] [Abstract][Full Text] [Related]
8. Platelet-to-Lymphocyte Ratio Predicts Contrast-Induced Acute Kidney Injury in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Velibey Y; Oz A; Tanik O; Guvenc TS; Kalenderoglu K; Gumusdag A; Akdeniz E; Bozbay M; Tekkesin AI; Guzelburc O; Hayiroglu MI; Alper AT; Ugur M; Eren M Angiology; 2017 May; 68(5):419-427. PubMed ID: 27473864 [TBL] [Abstract][Full Text] [Related]
9. Effect of continuous use of metformin on kidney function in diabetes patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Yu Q; Zhu JJ; Liu WX BMC Cardiovasc Disord; 2020 Apr; 20(1):187. PubMed ID: 32316910 [TBL] [Abstract][Full Text] [Related]
10. Hydration for prevention of kidney injury after primary coronary intervention for acute myocardial infarction: a randomised clinical trial. Liu Y; Tan N; Huo Y; Chen S; Liu J; Chen YD; Wu K; Wu G; Chen K; Ye J; Liang Y; Feng X; Dong S; Wu Q; Ye X; Zeng H; Zhang M; Dai M; Duan CY; Sun G; He Y; Song F; Guo Z; Chen PY; Ge J; Xian Y; Chen J Heart; 2022 May; 108(12):948-955. PubMed ID: 34509996 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of post-procedural oral hydration volume on risk of contrast-induced acute kidney injury following primary percutaneous coronary intervention: study protocol for a randomized controlled trial. Song F; Sun G; Liu J; Chen JY; He Y; Liu L; Liu Y; Trials; 2019 May; 20(1):290. PubMed ID: 31133052 [TBL] [Abstract][Full Text] [Related]
12. Predictive value of two different definitions of contrast-associated acute kidney injury for long-term major adverse kidney events in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Chen L; Wang X; Wang Q; Ding D; Jiang W; Ruan Z; Zhang W Cardiol J; 2024; 31(1):53-61. PubMed ID: 35578758 [TBL] [Abstract][Full Text] [Related]
13. The relationship between hyperuricemia and contrast-induced acute kidney injury undergoing primary percutaneous coronary intervention: secondary analysis protocol for the ATTEMPT RESCIND-1 study. Guo W; Song F; Chen S; Zhang L; Sun G; Liu J; Chen J; Liu Y; Tan N; Trials; 2020 Jun; 21(1):567. PubMed ID: 32580757 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of neutrophil gelatinase-associated lipocalin and cystatin C as biomarkers of acute kidney injury after ST-segment elevation myocardial infarction treated by percutaneous coronary intervention. Nguyen LS; Spagnoli V; Kerneis M; Hauguel-Moreau M; Barthélémy O; Collet JP; Montalescot G; Silvain J Arch Cardiovasc Dis; 2019 Mar; 112(3):180-186. PubMed ID: 30639197 [TBL] [Abstract][Full Text] [Related]
15. A comparison between two different definitions of contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Centola M; Lucreziotti S; Salerno-Uriarte D; Sponzilli C; Ferrante G; Acquaviva R; Castini D; Spina M; Lombardi F; Cozzolino M; Carugo S Int J Cardiol; 2016 May; 210():4-9. PubMed ID: 26921538 [TBL] [Abstract][Full Text] [Related]
16. Contrast-induced acute kidney injury and mortality in ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Silvain J; Nguyen LS; Spagnoli V; Kerneis M; Guedeney P; Vignolles N; Cosker K; Barthelemy O; Le Feuvre C; Helft G; Collet JP; Montalescot G Heart; 2018 May; 104(9):767-772. PubMed ID: 29092921 [TBL] [Abstract][Full Text] [Related]
17. Elevated serum uric acid is a predictor of contrast associated acute kidney injury in patient with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Mandurino-Mirizzi A; Kajana V; Cornara S; Somaschini A; Demarchi A; Galazzi M; Crimi G; Ferlini M; Camporotondo R; Gnecchi M; Ferrario M; Oltrona-Visconti L; De Ferrari GM Nutr Metab Cardiovasc Dis; 2021 Jun; 31(7):2140-2143. PubMed ID: 34039505 [TBL] [Abstract][Full Text] [Related]
18. Acute Kidney Injury After Primary Angioplasty: Is Contrast-Induced Nephropathy the Culprit? Caspi O; Habib M; Cohen Y; Kerner A; Roguin A; Abergel E; Boulos M; Kapeliovich MR; Beyar R; Nikolsky E; Aronson D J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28647690 [TBL] [Abstract][Full Text] [Related]
19. Outcomes of early and reversible renal impairment in patients with ST segment elevation myocardial infarction undergoing percutaneous coronary intervention. Khoury S; Margolis G; Ravid D; Rozenbaum Z; Keren G; Shacham Y Eur Heart J Acute Cardiovasc Care; 2020 Oct; 9(7):684-689. PubMed ID: 30328697 [TBL] [Abstract][Full Text] [Related]
20. Role of modified hydration for preventing contrast-associated acute kidney injury in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention. Liu L; Zhou L; Li W; Chen H; Li H Intern Emerg Med; 2023 Jan; 18(1):67-76. PubMed ID: 36539602 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]